Table 1 Characteristics of included trials
Characteristic | Trials (n = 9) (%) |
|---|---|
Type of trial | |
CTIMP | 3 (33%) |
Device | 1 (11%) |
Intervention | 5 (56%) |
Stage of trial | |
Definitive | 6 (67%) |
Feasibility | 3 (33%) |
Funding type | |
NIHR | 8 (89%) |
Industry | 1 (11%) |
Clinical area | |
Dermatology | 3 (33%) |
Diabetes | 1 (11%) |
Gastroenterology | 1 (11%) |
Hand surgery | 1 (11%) |
Pregnancy and childbirth | 2 (22%) |
Sexual health | 1 (11%) |
Population | |
Adults | 6 (67%) |
Paediatric | 2 (22%) |
Adults and paediatric | 1 (11%) |
Sample size | |
Mean (SD) | 549.6 (648.6) |
Median (IQR) | 269 (180, 517) |
Min, Max | 50, 1900 |
Length of recruitment (months) | |
Mean (SD) | 23.6 (11.7) |
Median (IQR) | 22.4 (17.1, 26.1) |
Min, Max | 10.0, 44.4 |
Number of sitesa | |
Mean (SD) | 13.9 (8.1) |
Median (IQR) | 16 (8, 22) |
Min, Max | 3, 25 |